This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Moran, N. Affymax poised to challenge Amgen. Nat Biotechnol 30, 377–378 (2012). https://doi.org/10.1038/nbt0512-377
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt0512-377
This article is cited by
-
Fresh from the biotech pipeline—2012
Nature Biotechnology (2013)
-
Amgen to shut key plant
Nature Biotechnology (2012)